07:26 AM EDT, 06/27/2024 (MT Newswires) -- Elanco Animal Health ( ELAN ) said Thursday that it has made progress in gaining US Food and Drug Administration approval for its drugs Zenrelia and Credelio Quattro.

For Zenrelia, the company said it expects approval in Q3 followed by a US launch in Q4.

For Credelio Quattro, the company said it expects approval in Q4 and an anticipated US launch in Q1.

The company said it is increasing its expectations of innovation sales this year to $400 million to $450 million, up from $375 million to $410 million previously.

Price: 17.50, Change: -0.74, Percent Change: -4.06